M. Takamori et al., SYNAPTOTAGMIN CAN CAUSE AN IMMUNE-MEDIATED MODEL OF LAMBERT-EATON MYASTHENIC SYNDROME IN RATS, Annals of neurology, 35(1), 1994, pp. 74-80
The possible antigenicity of synaptotagmin, a synaptic vesicle protein
acting as a cooperative calcium (Ca2+) receptor in exocytosis, was te
sted to determine whether it is involved in the induction of Lambert-E
aton myasthenic syndrome in which antibodies against voltage-dependent
Ca2+ channels or related molecules play a pathogenic role. Repeated i
njections to Lewis rats with peptides of synaptotagmin residues 20 thr
ough 53 or 1 through 30 that are presumably exposed at the nerve termi
nal surface during exocytosis induced corresponding antipeptide antibo
dies; on immunoblots, antibodies recognized synaptotagmin that was exp
ressed in the clonal cells. Electrophysiologically, the peptide (resid
ues 20-53)-immunized rats showed (1) reduced acetylcholine quantal con
tent of end-plate potential, (2) an increase in quantal content at hig
h extracellular Ca2+ concentration, and (3) early facilitation followe
d by less marked depression of end-plate potential amplitude at a teta
nic rate of repetitive nerve stimulation Findings We similar to those
in human Lambert-Eaton myasthenic syndrome and passively transferred L
ambert-Eaton myasthenic syndrome in mice, and thus suggest that antibo
dy to a synaptotagmin-voltage-dependent Ca2+ channel complex may be in
volved in the pathogenesis of Lambert-Eaton myasthenic syndrome. The p
eptide (residues 1-30)-immunized tars showed no electrophysiological a
bnormality.